As the COVID-19 pandemic and concerns surrounding a second wave of infections continue through autumn, public health concerns remain a top priority for people both in and outside the healthcare industry.
As the scientific obstacles to developing a COVID-19 vaccine start to recede, the logistical hurdles to injecting it into the arms of billions of people worldwide are just beginning, according to Oliver Wyman Partners Fritz Heese, Health & Life Sciences, Michael Lierow, Transportation & Retail and Tushar Narsana, Automotive & Aerospace. Oliver Wyman is an affiliate of Guy Carpenter.
Two companies have now shared positive preliminary results for a coronavirus vaccine. The shot developed by Moderna can be stored at standard refrigerator temperatures for up to a month. The vaccine announced by Pfizer and BioNTech, made from messenger RNA technology, will need to be kept at about minus 75 degrees Celsius, thawed and injected within five days – or else re-iced in under one minute – or it will go bad.